ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

EMEND Improved Emesis In Men And Women, Trials Find

December 26, 2003

New International Policy On Clinical Trials Is Needed, Veronesi Says

October 21, 1983

In Brief: HHS Finds Fisher, Wickerham, Redmond Did Not Commit Scientific Misconduct

March 7, 1997